Every 2 minutes, a child is diagnosed with cancer. 💔
This Childhood Cancer Awareness Month, will you join us to take childhood back from cancer?
Like and retweet to raise awareness. 💡
Cool story led by Dr Ishwar Navin in our lab about how the positive effects of eliminating an inhibitory receptor doesn’t have anything to do with negating inhibitory signaling!
Dr. Robin Parihar (@RobinP_MDlab) and team at @bcmhouston highlight a novel non canonical role for TIGIT in modulating CAR-NK activity that may guide strategies to overcome inhibitory NK receptors and improve efficacy of CAR NKs against solid tumors.
👉 https://t.co/lw36Mj2AHn
This year, the OSI has awarded $1.1 million to investigators undertaking three different osteosarcoma research projects. Learn about the grant recipients here: https://t.co/yDSfuHfXuP
@BCCancer@WCMpeds@RobinP_MDlab@bcmhouston
Excited to share our work on expanding the antigen repertoire for EBVSTs immunotherapy aimed at EBV-associated malignancies. Thankful to Dr. Rooney for her invaluable mentorship. https://t.co/kki3drRncz
Check out our new paper! Perivascular niche in recurrent GBM has niche-specific macrophages interacting with endothelial cells and fibroblast-like cells. TME diversity, ECM texture - a ton of image analysis and spatial transcriptomics by 🌟Ugoma Onubogu! https://t.co/j7wJWBZlXx
Wanna move CRISPR genome editing to the clinics? Wanna to build tech to tackle the big challenges of cell therapy? 🧬✂️🩸
Join us as a Postdoc at @CAGTHouston@bcmhouston - Please RT 🙏
https://t.co/CxVUp1Q1dY